跳至主要内容
临床试验/EUCTR2013-000615-24-BE
EUCTR2013-000615-24-BE进行中(未招募)不适用

Tacrolimus disposition in pediatric transplantation: influence of age,genetic polymorphisms, intestinal and hepatic relative contribution onpharmacokinetics, in relationship with clinical outcomes

Cliniques universitaires Saint-Luc0 个研究点开始时间: 2014年2月7日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Children aged 0 to 18 years old
  • First liver transplant
  • Patient eligible to receive tacrolimus post transplant
  • Parents' approval to participate
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 60
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Multiorgan transplantation
  • ABO incompatible patients (unless aged less than 1 year and AB antibody <1/32)
  • Retransplantation
  • Multi organ failure
  • Introduction of tacrolimus administration postponed after day 3 post transplantation
  • Need for additional steroid therapy except methylprednisolone to treat rejection
  • Need for intraveinous tacrolimus
  • Consent refusal or incapacity to understand the study procedures
  • Retransplantation
  • Multiorgan transplantation
  • Introduction of tacrolimus administration postponed after

研究者

相似试验